Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F12%3A00390403" target="_blank" >RIV/68081707:_____/12:00390403 - isvavai.cz</a>
Alternative codes found
RIV/00159816:_____/12:#0000929
Result on the web
<a href="http://dx.doi.org/10.1155/2012/318087" target="_blank" >http://dx.doi.org/10.1155/2012/318087</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1155/2012/318087" target="_blank" >10.1155/2012/318087</a>

Result language
angličtina
Original language name
Arginine-Based Inhibitors of Nitric Oxide Synthase: Therapeutic Potential and Challenges
Original language description
In the past three decades, nitric oxide has been well established as an important bioactive molecule implicated in regulation of cardiovascular, nervous, and immune systems. Therefore, it is not surprising that much effort has been made to find specificinhibitors of nitric oxide synthases (NOS), the enzymes responsible for production of nitric oxide. Among the many NOS inhibitors developed to date, inhibitors based on derivatives and analogues of arginine are of special interest, as this category includes a relatively high number of compounds with good potential for experimental as well as clinical application.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
BO - Biophysics
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)